Control Print Ltd Q1 FY27 Earnings Analysis

- Expecting 15-20% growth in sales for subsidiaries CODEOLOGY and MARKPRINT (Page 27). - Packaging business expansion in Guwahati to benefit from incentives and reduce costs, supporting growth (Page 33). - Coding and marking business in India is steady with reasonable growth expected; around 3,000 printers sold in FY26 (Pages 30, 28). - Track and Trace business is currently INR 500-600 crores market; focus on differentiated IP-based solutions aiming for breakeven and profitability this year, with pilots nearing completion (Pages 16-17, 12). - CP Italy subsidiary has losses but growth potential exists if machines are shipped and deployed (Page 27). - Overall, growth is expected from volume increases, new product platforms, and strategic investment in IP-driven technologies (Pages 30-31).

- Control Print expects around 15-20% top-line growth in subsidiaries CODEOLOGY and MARKPRINT. - Losses in CP Italy are the main consolidated losses; efforts are ongoing to improve this. - The Track and Trace business, a ~INR500-600 crore market, aims to redefine market approaches and currently is at breakeven or profitable, expected to contribute positively going forward. - V-Shapes subsidiary might breakeven in FY27 with losses reducing progressively; limited future fund infusion expected. - Coding and marking business remains the core, steady and profitable with price increases and cost optimizations. - Long-term focus is on building differentiated IP and new platforms for sustainable growth over a decade horizon. - Profit margins at the corporate level expected to maintain or improve as new ventures mature. - Management emphasizes patience and ongoing investment to realize significant growth and profitability gains.

- Control Print has made significant investments in the packaging business, including acquiring technology and expanding manufacturing capacity (e.g., new facility in Guwahati). - Capex includes INR15 crore in plant and machinery to avail incentives in the Northeast expansion; benefits include INR7.5 crore cashback, 5% interest subsidy for six years, and GST refunds over 10 years. - Additional investments related to V-Shapes subsidiary, with expected breakeven potentially this year; last infusion of around EUR1-2 million aimed at technology and inventory. - The company is investing continually in developing IP and new products, particularly in Track and Trace business, which is moving toward breakeven and profitability. - Strategic move to bring packaging IP under Control Print’s ownership, enabling licensing opportunities and potential platform creation. - New investments aim at long-term growth by building differentiated technology platforms rather than incremental expansions in coding and marking business.

- There is no specific mention of any current or planned new fundraising through debt or equity during the Q4 & FY26 post earnings call. - The management indicates that most of the investment required for subsidiaries like V-Shapes and packaging businesses have already been made. - Shiva Kabra mentions that additional funds are unlikely to be infused into V-Shapes post the current phase. - The company focuses on continuing investments internally, especially in IP development for Track and Trace and packaging business. - The discussion suggests a cautious approach by the board on further capital allocation with significant progress being made towards profitability and breakeven. - Licensing of technology and alternative business models are being considered, which might reduce the need for fresh capital infusion. - Overall, no explicit plans for raising new debt or equity were disclosed on the call.

- For the packaging business (especially V-Shapes), some machines are stuck at the factory due to design/specification changes, delaying shipments and revenue recognition. - Once these machines ship out, inventory converts to revenue and leads to recurring revenue. - Difficulties in shipping materials to customers in Gulf and Middle East regions have impacted sales. - For the coding and marking business (e.g., CODEOLOGY and MARKPRINT), the business is steady with expected 15-20% growth. - The Track and Trace business is progressing with pilots in top pharmaceutical companies; if successful, larger rollouts are expected. - Overall, the company expects that pending orders for packaging machines will convert to revenue once specification issues are resolved, potentially improving order fulfillment soon.